647 related articles for article (PubMed ID: 34390376)
41. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.
Levin MJ
J Clin Virol; 2014 Dec; 61(4):487-95. PubMed ID: 25453570
[TBL] [Abstract][Full Text] [Related]
42. [TaqMan fluorescent probe-based real-time PCR assay for detection of varicella-zoster virus].
Kierat S; Leś K; Przybylski M; Dzieciatkowski T; Młynarczyk G
Med Dosw Mikrobiol; 2012; 64(2):139-49. PubMed ID: 23072059
[TBL] [Abstract][Full Text] [Related]
43. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.
Betta M; Laurino M; Pugliese A; Guzzetta G; Landi A; Manfredi P
Proc Biol Sci; 2016 Mar; 283(1826):20160054. PubMed ID: 26984627
[TBL] [Abstract][Full Text] [Related]
44. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
[TBL] [Abstract][Full Text] [Related]
45. Chronic Headache and Cerebral Venous Sinus Thrombosis Due to Varicella Zoster Virus Infection: A Case Report and Review of the Literature.
Alamlih L; Abdulgayoom M; Menik Arachchige SN; Shah MH; Zahid M
Am J Case Rep; 2021 Mar; 22():e927699. PubMed ID: 33727523
[TBL] [Abstract][Full Text] [Related]
46. Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.
Brosh-Nissimov T; Sorek N; Yeshayahu M; Zherebovich I; Elmaliach M; Cahan A; Amit S; Rotlevi E
Vaccine; 2021 Sep; 39(40):5729-5731. PubMed ID: 34481701
[TBL] [Abstract][Full Text] [Related]
47. Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine.
de Martino Mota A; Carvalho-Costa FA
J Pediatr (Rio J); 2016; 92(4):361-6. PubMed ID: 26969400
[TBL] [Abstract][Full Text] [Related]
48. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
[TBL] [Abstract][Full Text] [Related]
49. Clinical reinfection with varicella-zoster virus.
Gershon AA; Steinberg SP; Gelb L
J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
[TBL] [Abstract][Full Text] [Related]
50. Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.
Fathy RA; McMahon DE; Lee C; Chamberlin GC; Rosenbach M; Lipoff JB; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Fassett M; Fox LP; Greenberg HL; Blumenthal K; Freeman EE
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e6-e9. PubMed ID: 34487581
[No Abstract] [Full Text] [Related]
51. Varicella zoster meningitis: an atypical case of zoster reactivation in immunocompetent young adult.
Khaliq MF; Kochar T; John M
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29305370
[TBL] [Abstract][Full Text] [Related]
52. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
53. Varicella infection caused by Oka strain vaccine in a heart transplant recipient.
Kraft JN; Shaw JC
Arch Dermatol; 2006 Jul; 142(7):943-5. PubMed ID: 16847227
[No Abstract] [Full Text] [Related]
54. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
55. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
56. Shingrix for Herpes Zoster: A Review.
Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
[TBL] [Abstract][Full Text] [Related]
57. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.
Baird NL; Zhu S; Pearce CM; Viejo-Borbolla A
Viruses; 2019 Jan; 11(2):. PubMed ID: 30691086
[TBL] [Abstract][Full Text] [Related]
58. Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
Beals CR; Railkar RA; Schaeffer AK; Levin Y; Kochba E; Meyer BK; Evans RK; Sheldon EA; Lasseter K; Lang N; Weinberg A; Canniff J; Levin MJ
Lancet Infect Dis; 2016 Aug; 16(8):915-22. PubMed ID: 27061887
[TBL] [Abstract][Full Text] [Related]
59. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
60. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
Tsolia M; Gershon AA; Steinberg SP; Gelb L
J Pediatr; 1990 Feb; 116(2):184-9. PubMed ID: 2153790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
